Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Understanding what not to do when investing in crypto can save you from significant losses. Equip yourself with the right knowledge.
26,979 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Lumentum shares jumped about 12% on a $2 billion NVIDIA partnership, as AI data-center buildout and robust backlog un...
Oil prices remain a key driver for energy stocks. This article highlights three dividend-friendly picks—Chevron, Exxo...
A private AI startup is offering a sub-$1 pre-IPO round open to retail investors, pricing shares at $0.66 and promisi...
Nvidia delivered a record-breaking quarter, but a steely market mood leaves its stock rangebound. A steward partners ...
Gold is leading gains in early 2026, while silver remains volatile. Analysts say the evolving ETF landscape is paving...
Gold flirts with bear-market as risk appetite wobbles amid rising rates and Middle East tensions. Traders weigh margi...
A major European energy firm plans to halt offshore wind projects off the U.S. East Coast and redirect about $1B into...
Bank of America upgrades Oracle to Buy, signaling potential upside as AI-driven cloud demand and a massive backlog cr...
Disney, McDonald’s, Microsoft, and Procter & Gamble now appear oversold despite solid earnings and durable consumer s...
A California court has ruled that addictive features in social apps can harm mental health, a verdict with potential ...
Oil-driven weakness pushed the S&P 500 lower in a volatile March session. SPY skidded as energy names led declines, w...